In a special feature to celebrate International Women’s Day on March 8, Ellie Mertens speaks to counsel at Uber, Xerox, Micron and others about women in IP – the progress and the path
Managing Intellectual Property is delighted to publish the IP STARS 2019 rankings of the leading firms for patent work. This is the second set of results from the research for IP STARS 2019, which started in September 2018. The rankings over the following pages cover more than 50 jurisdictions.
John Pegram of Fish & Richardson considers the impact of Brexit on non-European IP owners, arguing that foreign companies will be less likely to use the UK as their point of entry into the EU
Christian Liedtke of Acuminis examines the possibly far-reaching changes to US trademark practice rules seeking to abolish the ability of foreign trademark holders to represent themselves in trademark matters before the USPTO and its Trademark Trial and Appeal Board
Paul England of Taylor Wessing says there are two Brexit possibilities that pharma and medical devices companies really need to be aware of. Here he explains what their impact is likely to be on patents and regulatory rights
The US Federal Circuit has imposed restrictions on who can appeal against an inter partes review decision, making life difficult for some petitioners. However, there are some practical tips to consider, as Rose Cordero Prey and Eric Ding of Greenberg Traurig explain
China and Hong Kong have signed an agreement that allows the jurisdictions to mutually recognise one another’s IP judgments. George Chan, Vera Zuo, Wenyi Liu and Joy Shi of Simmons & Simmons provide an overview of the changes and how they will benefit IP owners
Despite agreeing to leave the EU, the UK has implemented some important EU-wide trademark reforms into its national system. Kate Swaine and Elwin Morgan of Gowling WLG give a rundown of what will change in practice
A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam
September / October 2019
Should I stay or should I go? Private practice v in-house
In-house or private practice? It’s a question many lawyers and attorneys will probably ask themselves at some stage in their career, as Managing IP finds out
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2019 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International